CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Aims to Deliver Safer Alternative for Nicotine Experience
May 19, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) will soon begin a human clinical study, NIC-H22-1, to compare its DehydraTECH-nicotine pouch performance with that of existing brands such as ON! and Zyn, currently available in the U.S. “Animal testing has already demonstrated that DehydraTECH-nicotine can deliver peak nicotine performance to the bloodstream 10 to 20 times faster than the study’s controls,” a recent article reads. “Lexaria has long held that any form of inhaling chemical substances can be detrimental to health, and its DehydraTECH-nicotine aims to help vapers as well as smokers wean themselves off of those products, giving them relief from cravings while offering a safer nicotine alternative. ‘My father also died from lung cancer … so I am no fan [of smoking],’ CEO Chris Bunka told Forbes in 2019. ‘The fact that [DehydraTECH] is fast means that smokers might not be frustrated waiting for their nicotine experience to begin, the way they have been with traditional nicotine products such as gums and lozenges.’”
To view the full article, visit https://cnw.fm/UO4Jl
About Lexaria Bioscience Corp.
Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is part of the InvestorBrandNetwork.
More News
British TV viewers suffering from 'streaming overload' because they are 'overwhelmed by choice' - with millions calling for a 'return to simpler times'
TV viewers are said to be suffering with 'streaming overload' - with millions calling for a 'return to simpler times'
As 1 mainland Chinese chip IPO soars, another stumbles in busy Hong Kong week
Two mainland Chinese chip suppliers made sharply divergent trading debuts in Hong Kong on Tuesday after raising a combined HK$2.2 billion (US$280 million), underscoring investors’ selective appetite for semiconductor stocks despite a pickup in new listings. Suzhou Denglin Technology, the week’s largest listing, fell by as much as 8.6 per cent in morning trade after raising HK$1.4 billion in its initial public offering (IPO). The graphics processing unit maker priced its shares at HK$231 – the...
Nvidia CEO Jensen Huang reportedly hired scandal-management PR firm before affair controversy surfaced
Nvidia CEO Jensen Huang reportedly hired crisis communications firm Heller Inc a year before acknowledging an affair with a former Megaspeed executive suspected of links to Chinese intelligence.
Chinese biotech giant WuXi AppTec’s shares jump after Pentagon blacklist reversal
WuXi AppTec’s shares jumped on Tuesday after the Pentagon removed the company from a list of entities allegedly linked to the Chinese military, marking a win for the biotech service giant and raising hopes among other mainland firms challenging US blacklists. The US deputy secretary of defence decided to delist WuXi AppTec from its list of “Chinese military companies”, according to a notice published on the Federal Register on Tuesday. WuXi AppTec surged more than 6 per cent at the open in Hong...
Chinese traders still confident of Nvidia GPU access amid Jensen Huang scandal
Prices for Nvidia graphics processing units (GPUs) are falling in China’s largest electronics market, as traders shrug off the frenzy of market speculation over tightening export controls in the wake of the US midterm elections and the Jensen Huang affair. The US chip giant’s top-of-the-range GeForce RTX 5090 graphics card surged in price last month at Shenzhen’s Huaqiangbei market, but that was mostly driven by rumours that Nvidia was going to halt production to focus on high-end enterprise...
Trump says FBI investigating Nvidia boss's affair with alleged Chinese spy
The US president said he spoke with Jensen Huang on Monday and asked him about the affair with the alleged spy.
Australia to mandate AI breach reporting, create regulator after OpenAI breach
OPENAI-CYBERSECURITY-AUSTRALIA:Australia to mandate AI breach reporting, create regulator after OpenAI breach
Qantas to outsource 850 local jobs with most roles moving to India
The Australian airline said the move was aimed at modernising its IT systems and noted the impact of AI.
What Is Congress’s Plan to Speed Up Energy Permits?
The sprawling bill, which has divided Democrats, would overhaul major environmental laws to streamline the permitting process.
Iran War Unexpectedly Drove Down Carbon Emissions This Year
It’s the first drop in planet-warming pollution since the pandemic in 2020. But researchers cautioned that the decline could be short-lived.
Less coupon math, more AI: what’s new for China’s 18th Singles’ Day
For Sunny He, a 32-year-old Shanghai resident, this year’s Singles’ Day shopping season culminated in a single, high-value purchase: a 12,000-yuan (US$1,797) iPhone 18 Pro Max, sweetened by a 300-yuan voucher on Alibaba Group Holding’s Tmall marketplace. “For me, Double 11 definitely isn’t as lively as before because I have less spare cash than in previous years,” He said. “Even so, I’ll take advantage of this chance for products that I couldn’t bear to buy at full price, like a new...
The superpower battle over energy – and what it means for your bills
A tug-of-war between China and the US could have a big impact on energy costs, but who will win?
Recommended
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.